ALLERGENS IN SENSITIVE COSMETICS
European Union
Public comments are being sought on recently published scientific opinion by SCCS on safety of salicylic acid in cosmetic products whereby the committee agrees that the use of salicylic acid as a preservative up to a maximum concentration of 0.5…
Scientific Committee on Consumer Safety published scientific advice on the safety of triclocarban and triclosan as substances with potential endocrine disrupting properties in cosmetic products.
On November 04, 2022, the Scientific Committee on Consumer Safety issued its advice on safety of triclocarban and triclosan as substances with potential endocrine disrupting properties in cosmetic products.
On October 06, 2022, the Cosmetic, Toiletry and Perfumery Association (CTPA) has published a paper detailing the association’s position on the use of ’free from’ claims, including claims with a similar meaning, for cosmetic and personal care…
In order to show its support to transition towards a circular economy and the reuse of packaging and thereby preventing excess waste generation, CTPA has launched a guidance on the supply of cosmetic and personal care products in formats allowing…
On September 15, 2022, WTO publlished a notification informing about a draft measure proposed by the EU requiring cosmetic products containing fragrance allergens to be labelled on the product packaging, if their concentration is more than 0.001…
European Commission publish the Omnibus Act V, which bans 14 substances. Moreover, Methyl salicylate will be restricted per category. Omnibus Act V will apply as of December 17, 2022, and there will be no adaptation time.
On September 15, 2022, the European Commission issued notification G/TBT/N/EU/924, publishing a draft amendment to Regulation No. 1223/2009 of the European Parliament and of the Council on the labelling of fragrance allergens in cosmetics.
In an interview, CEO of the Chemical Business Association (CBA) in the UK emphasised on challenges and multiple disruptions in the supply chains during the pandemic period at its peak.
